Indikationen zur intravitrealen Injektionstherapie mit Anti-VEGF für Makulaerkrankungen – Fehler vermeiden

Der Ophthalmologe ◽

10.1007/s00347-021-01553-8 ◽

2022 ◽

Author(s):

Carsten Framme ◽

Bernd Junker ◽

Nicolas Feltgen ◽

Hans Hoerauf ◽

Nina-Antonia Striebe ◽

...

Keyword(s):

Download Full-text

Anti-VEGF-Therapie aus kardiologischer Sicht

Klinische Monatsblätter für Augenheilkunde ◽

10.1055/s-0030-1270050 ◽

2010 ◽

Vol 227 (S 03) ◽

Author(s):

K Pels

Keyword(s):

Download Full-text

Diabetisches Makulaödem: Indikationen zur intravitrealen Anti-VEGF-Therapie und Laserkoagulation

Klinische Monatsblätter für Augenheilkunde ◽

10.1055/s-0031-1297321 ◽

2011 ◽

Vol 228 (S 02) ◽

Author(s):

A Gabel-Pfisterer ◽

F Heinemann ◽

G Baader

Keyword(s):

Diabetisches Makulaödem ◽

Download Full-text

Intravitreale Anti-VEGF-Therapie mit Bevacizumab bei diabetischem Makulaödem

Klinische Monatsblätter für Augenheilkunde ◽

10.1055/s-2006-948284 ◽

2006 ◽

Vol 223 (S 2) ◽

Author(s):

D Kook ◽

A Wolf ◽

AS Neubauer ◽

SG Priglinger ◽

A Hofer ◽

...

Keyword(s):

Download Full-text

Anti-VEGF bei reiner Pigmentepithelabhebung

Klinische Monatsblätter für Augenheilkunde ◽

10.1055/s-2007-970114 ◽

2007 ◽

Vol 224 (S 1) ◽

Author(s):

L Spetlikova ◽

O Rudolph ◽

R Effert

Keyword(s):

Download Full-text

Anti-VEGF-Therapie der serösen Pigmentepithelabhebung bei AMD

Klinische Monatsblätter für Augenheilkunde ◽

10.1055/s-2007-992961 ◽

2007 ◽

Vol 224 (S 4) ◽

Author(s):

A Lommatzsch

Keyword(s):

Download Full-text

The efficacy of anti-VEGF therapy in patients with bilateral myopic choroidal neovascularization depending on the time of treatment (clinical case)

Modern technologies in ophtalmology ◽

10.25276/2312-4911-2019-1-277-280 ◽

2019 ◽

pp. 277-280

Author(s):

N.V. Zaitseva ◽

◽

T.N. Iureva ◽

A.P. Yakimov ◽

◽

...

Keyword(s):

Choroidal Neovascularization ◽

Clinical Case ◽

Myopic Choroidal Neovascularization ◽

Download Full-text

Justification of optimal period for vitreoretinal intervention on the background of preoperative anti-VEGF therapy for proliferative diabetic retinopathy

POINT OF VIEW EAST – WEST ◽

10.25276/2410-1257-2020-3-13-15 ◽

2020 ◽

pp. 13-15

Author(s):

M.M. Bikbov ◽

◽

M.R. Kalanov ◽

T.R. Gilmanshin ◽

R.M. Zainullin ◽

...

Keyword(s):

Diabetic Retinopathy ◽

Proliferative Diabetic Retinopathy ◽

Anti Vegf ◽

Download Full-text

Changes оf vascular endothelial growth factor concentration in patients with exudative age related macular degeneration and primary open-angled glaucoma on the anti-VEGF therapy

POINT OF VIEW EAST – WEST ◽

10.25276/2410-1257-2018-2-59-62 ◽

2018 ◽

pp. 59-62

Author(s):

O.А. Zhabina ◽

◽

I.V. Andreeva ◽

A.S. Rudko ◽

A.A. Plyukhova ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Macular Degeneration ◽

Age Related Macular Degeneration ◽

Vascular Endothelial ◽

Anti Vegf ◽

Age Related ◽

Endothelial Growth Factor ◽

Factor Concentration

Download Full-text

Expert Consensus Optimization of the anti-VEGF treatment regimens with aflibercept in patients with neovascular age-related macular degeneration and visual impairment as a result of diabetic macular edema

Oftalmologicheskii Zhurnal ◽

10.31288/oftalmolzh201956467 ◽

2019 ◽

Vol 82 (5) ◽

pp. 64-67

Author(s):

◽

Keyword(s):

Visual Impairment ◽

Macular Degeneration ◽

Macular Edema ◽

Diabetic Macular Edema ◽

Age Related Macular Degeneration ◽

Expert Consensus ◽

Treatment Regimens ◽

Anti Vegf ◽

Age Related ◽

Consensus Optimization

Download Full-text

Anti-VEGF Therapy Versus Dexamethasone Implant for DME

Case Medical Research ◽

10.31525/ct1-nct03999125 ◽

2019 ◽

Author(s):

Keyword(s):

Dexamethasone Implant ◽

Download Full-text